AstraZeneca to resume vaccine trials after ‘potentially unexplained illness’ prompted pause
AstraZeneca announced that it was restarting phase three coronavirus vaccine trials after they were paused when a participant became ill. The pharmaceutical giant announced the resumption on Saturday after the trials were put on hold on Sunday. The patient in question, a woman, was from the United Kingdom and reportedly suffered a rare spinal cord… Read More: AstraZeneca to resume vaccine trials after ‘potentially unexplained illness’ prompted… »